FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Awards First-Ever National Priority Vouchers to Nine Sponsors
- FDA Conditionally Approves First Drug for Prevention and Treatment of New World Screwworm Infestations in Cattle
- A Statement From FDA Commissioner Marty Makary, M.D., M.P.H.: Encouraging Retailers to Stop Selling Illegal Vapes
- FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia
- FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)
- FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
- FDA Takes Action to Make a Treatment Available for Autism Symptoms
- FDA Grants Accelerated Approval to First Treatment for Barth Syndrome
- FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products
- HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation
- FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse
- FDA Launches Crackdown on Deceptive Drug Advertising
- FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children
- FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
- FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89